Cart
sales@molnova.com
LSN2463359
CAS No. 1401031-52-4
LSN2463359( —— )
Catalog No. M34321 CAS No. 1401031-52-4
LSN2463359 is a positive allosteric modulators of the mGlu5 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 46 | Get Quote |
|
| 10MG | 73 | Get Quote |
|
| 25MG | 159 | Get Quote |
|
| 50MG | 251 | Get Quote |
|
| 100MG | 363 | Get Quote |
|
| 200MG | 516 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLSN2463359
-
NoteResearch use only, not for human use.
-
Brief DescriptionLSN2463359 is a positive allosteric modulators of the mGlu5 receptor.
-
DescriptionLSN2463359 is positive allosteric modulator of metabotropic glutamate 5 (mGlu5). LSN2463359 attenuates aspects of the behavioral response to administration of the competitive NMDA receptor antagonist. LSN2463359 selectively attenuates reversal learning deficits observed in the neurodevelopmental MAM E17 model. LSN2463359 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorGluR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1401031-52-4
-
Formula Weight265.31
-
Molecular FormulaC16H15N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (471.15 mM; Ultrasonic )
-
SMILESCC(C)NC(=O)c1ccc(cn1)C#Cc1ccncc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gastambide F, et al. The mGlu? positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat. Neuropharmacology. 2013;64:240-247.?
molnova catalog
related products
-
LY2608204
LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
-
DL-AP3
DL-AP3 is a competitive group I metabotropic glutamate receptor antagonist and inhibitor of phosphoserine phosphatase.
-
KM02894
KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases.
